checkAd
    Intra-Cellular Therapies Aktie
    65,32
     
    USD
    +0,49 %
    +0,32 USD
    Letzter Kurs 02:00:00 Nasdaq
    65,27
     
    USD
    1.300 STK
    Geldkurs 20.05.24
    65,33
     
    USD
    700 STK
    Briefkurs 20.05.24
    ISIN: US46116X1019 · WKN: A1XDTL · SYM: ITCI · USA

    Neueste Nachrichten

    Intra-Cellular Therapies to Participate in Two Upcoming Investor Conferences
    08.05.24 · globenewswire · Intra-Cellular Therapies
    Intra-Cellular Therapies Reports First Quarter 2024 Financial Results
    07.05.24 · globenewswire · Intra-Cellular Therapies
    Intra-Cellular Therapies to Host First Quarter 2024 Financial Results Conference Call and Webcast
    30.04.24 · globenewswire · Intra-Cellular Therapies
    Intra-Cellular Therapies Announces Closing of $575 Million Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
    24.04.24 · globenewswire · Intra-Cellular Therapies
    Intra-Cellular Therapies Prices Public Offering of Common Stock
    18.04.24 · globenewswire · Intra-Cellular Therapies
    Intra-Cellular Therapies Announces Proposed Public Offering of Common Stock
    16.04.24 · globenewswire · Intra-Cellular Therapies
    Intra-Cellular Therapies Announces Positive Phase 3 Topline Results from Study 501 Evaluating Lumateperone as Adjunctive Therapy in Patients with Major Depressive Disorder
    16.04.24 · globenewswire · Intra-Cellular Therapies
    Fokus Aktien mit extremen Handelsvolumen am Donnerstag, den 04.04.2024
    04.04.24 · wO Chartvergleich · Banco Bradesco
    Intra-Cellular Therapies Announces Executive Appointments and Leadership Changes
    19.03.24 · globenewswire · Intra-Cellular Therapies
    Intra-Cellular Therapies to Participate in Three Upcoming Investor Conferences
    06.03.24 · globenewswire · Intra-Cellular Therapies
    Intra-Cellular Therapies to Present at the 44th Annual TD Cowen Health Care Conference
    27.02.24 · globenewswire · Intra-Cellular Therapies
    Intra-Cellular Therapies Reports Fourth Quarter And Full-Year 2023 Financial Results And Provides Corporate Update
    22.02.24 · globenewswire · Intra-Cellular Therapies